Freyholdt T - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Page 1

Sodium nitroprusside in patients with compromised left ventricular function undergoing coronary bypass: reduction of cardiac proinflammatory substances.

Massoudy P, Zahler S, Freyholdt T, Henze R, Barankay A, Becker BF, Braun SL, Meisner H. Massoudy P, et al. Among authors: freyholdt t. J Thorac Cardiovasc Surg. 2000 Mar;119(3):566-74. doi: 10.1016/s0022-5223(00)70138-3. J Thorac Cardiovasc Surg. 2000. PMID: 10694618 Free article. Clinical Trial.

Beneficial effect of sodium nitroprusside after coronary artery bypass surgery: pump function correlates inversely with cardiac release of proinflammatory cytokines.

Freyholdt T, Massoudy P, Zahler S, Henze R, Barankay A, Becker BF, Meisner H. Freyholdt T, et al. J Cardiovasc Pharmacol. 2003 Sep;42(3):372-8. doi: 10.1097/00005344-200309000-00008. J Cardiovasc Pharmacol. 2003. PMID: 12960682 Clinical Trial.

Efficacy of triplet combination chemotherapy with oxaliplatin, irinotecan and capecitabine (OCX) in metastatic colorectal cancer in relation to RAS/RAF mutation status: results of a retrospective analysis.

Brunner S, von Moos R, Mey U, Camenisch Gross U, Freyholdt T, Cathomas R. Brunner S, et al. Among authors: freyholdt t. Oncol Res Treat. 2014;37(11):646-52. doi: 10.1159/000368313. Epub 2014 Oct 17. Oncol Res Treat. 2014. PMID: 25427581

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Search Page

Filters